AMAPPAMAPP
Media

AMAPP in the national conversation.

Australian media have turned to AMAPP for comment since the TGA's decision to down-schedule psychedelic medicines. This page collects that coverage, along with contact details for journalists.

Media enquiriesOur position statement
Press coverage

On the record, in print and on air

Coverage to date centres on the TGA's decision to down-schedule psychedelic medicines: how they are rolled out safely, and what practitioners need from the regulatory system.

PACFA News · August 2025

AMAPP Calls for Inclusive, Competency-Based Psychedelic Workforce

Mentions AMAPP

PACFA's coverage of AMAPP's workforce policy submission.

Read the full story

ABC News · 7.30 · February 2024 · by Peter McCutcheon

Safety First in Medicine Rollout

Featuring Dr Anthony Bloch, then AMAPP Chair

“The main concern was not to get the medicine to as many people as possible - but how to get the medicine safely rolled out.”

Dr Anthony Bloch · Former AMAPP Chair

Read the full story

NT Independent · 27 January 2024

Opinion: Urgent need for review of psychedelic therapy rules

Written by Dr Anthony Bloch, then AMAPP Chair

Read the full story

The Microdose · December 2023 · by jane c. hu

News roundup: Taking expectancy effects seriously

Mentions AMAPP

A UC Berkeley Graduate School of Journalism roundup covering AMAPP's press release calling for a comprehensive review, quoting Dr Bloch.

Read the full story

ABC News · November 2023 · by Sian Johnson

The use of psychedelic drugs to treat mental illness is allowed in Australia, but confusion remains

Featuring Dr Anthony Bloch, then AMAPP Chair

“The current regulatory system is virtually unworkable, overly cautious and cumbersome and needs to evolve with the help and input from those practitioners who have appropriate knowledge and experience working in the psychedelic field.”

Dr Anthony Bloch · Former AMAPP Chair

Read the full story

Hospital + Healthcare · November 2023

Call for review of 'inadequate' psychedelic-assisted therapy laws

Featuring Dr Anthony Bloch, then AMAPP Chair

News coverage of AMAPP's call for review of the psychedelic-assisted therapy laws.

Read the full story

The Medical Republic · November 2023

Groundbreaking psychedelics ruling not groundbreaking enough

Featuring Dr Anthony Bloch, then AMAPP Chair

“The Australian Multidisciplinary Association for Psychedelic Practitioners (AMAPP) aren't the first group to criticise the TGA's unexpected decision to down-schedule psychedelic medicines, but they're one of the only ones to argue it didn't go far enough.”

Holly Payne · The Medical Republic

Read the full story

RACGP newsGP · November 2023 · by Michelle Wisbey

Plea for psychedelic rules reform

Featuring Dr Anthony Bloch, then AMAPP Chair

AMAPP's urgent appeal for review of the psychedelic prescribing rules.

Read the full story

PACFA News · September 2023

PACFA meets with AMAPP

Mentions AMAPP

PACFA's report of its meeting with AMAPP.

Read the full story
Our advisors

Advisors in the media

AMAPP's advisors are among the most published and most quoted voices in Australian psychedelic science, ethics, and harm reduction. Below is a selection of their psychedelic-related writing, research, interviews, and media appearances, grouped by advisor.

Dr Martin Williams

Dr Martin Williams

PhD · Senior Research Fellow, Swinburne University · Executive Director, PRISM · Vice-President, EGA

Dr Sandra Dreisbach

Dr Sandra Dreisbach

Ethicist · PhD Philosophy · Community leader, EPIC · Ethics Director, World Psychedelics Day

Dr Alex De Foe

Dr Alex De Foe

Founding Director, Australian Centre for Consciousness Studies · Lecturer, Monash University · Associate Editor, Journal of Psychedelic Studies

Melissa Warner

Melissa Warner

Secretary, PRISM · Co-founder, Australian Psychedelic Society · Co-director, Cyberdelic Society · Research Associate, Swinburne

Dr Simon Beck

Dr Simon Beck

MD · Psychedelic harm-reduction advocate · Secretary, Australian Psychedelic Society (also published as “Symon Beck”)

Dr Nikola Ognyenovits

Dr Nikola Ognyenovits

MD · FRACGP · FAChAM · Psychedelic therapist and addiction medicine specialist

Michael Raymond

Michael Raymond

RAAF veteran · Veteran advocate · Co-Founder & CEO, Heroic Hearts Project Australia · Ambassador, Neuromedicines Discovery Centre

Dr Llew Lewis

Dr Llew Lewis

Psychiatrist · Fellow RANZCP · Principal Investigator, psilocybin trial for treatment-resistant depression · Founder, Rainbow Mandala Clinic (KAP)

Dr Anthony Helman

Dr Anthony Helman

Psychedelic medicine specialist · General practitioner and GP supervisor · Psychedelic psychotherapist

Media enquiries

Talk to AMAPP

Interview requests, comment, and background for stories on psychedelic-assisted therapies in Australia go straight to the AMAPP Chair.

Email chair@amapp.org.au
Where AMAPP stands

Read the position behind the quotes

Journalists quoting AMAPP can find the full background in our position statement and our policy and guidelines pages.

Position statementPolicy & guidelines